SureTrader
Interactive Brokers Advertisement
Home > Boards > Canadian > Cannabis > Invictus MD Strategies Corp (IVITF)

For those who are not familiar with Invictus

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
CannabidiolHead Member Profile
 
Followed By 3
Posts 259
Boards Moderated 0
Alias Born 03/24/16
160x600 placeholder
Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization "InvestorsHub NewsWire" - 11/27/2017 10:28:53 AM
Invictus MD Strengthens Management Team With Appointment of New CFO "InvestorsHub NewsWire" - 11/7/2017 9:21:26 AM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/24/2017 8:40:00 AM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd. "InvestorsHub NewsWire" - 8/11/2017 8:00:00 AM
Invictus MD's Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update "InvestorsHub NewsWire" - 7/14/2017 7:30:00 AM
Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc. "InvestorsHub NewsWire" - 7/13/2017 10:15:00 AM
Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF "InvestorsHub NewsWire" - 6/23/2017 10:16:23 AM
INVICTUS MD’S EXECUTIVE CHAIRMAN PROVIDES A CORPORATE UPDATE "InvestorsHub NewsWire" - 5/31/2017 8:38:00 AM
Invictus MD announces $20,000,000 Bought Deal Private Placement of Units "InvestorsHub NewsWire" - 5/8/2017 5:17:55 PM
Invictus MD Moves To TSX Venture Exchange "InvestorsHub NewsWire" - 4/6/2017 9:30:00 AM
Invictus MD's Chairman Provides March in Review "InvestorsHub NewsWire" - 4/5/2017 2:02:36 PM
Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market "InvestorsHub NewsWire" - 3/28/2017 10:30:02 AM
Invictus MD Announces Conditional Approval to List on the TSX Venture Exchange "InvestorsHub NewsWire" - 3/27/2017 10:55:10 AM
Invictus MD's AB Laboratories Inc. Provides Cultivation Update under ACMPR "InvestorsHub NewsWire" - 3/23/2017 12:44:32 PM
CannabidiolHead   Wednesday, 07/26/17 08:55:37 AM
Re: captainscotty post# 734
Post # of 1088 
For those who are not familiar with Invictus MD Strategies Corp., it is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the Access to Cannabis for Medical Purposes Regulations (ACMPR) located in both Alberta and Ontario, including Acreage Pharms Ltd. and AB Laboratories Inc.; fertilizer and nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd. Invictus MD targets small and mid-size companies with proven brands, strong customer focus, and significant growth potential. Invictus directs the strategy towards profitability and growth for each of their portfolio companies. They assist the companies with business process integration and by structuring and deploying proper capital to support sustained growth.

In our last review of Invictus MD Strategies Corp we outlined the pending bought deal private placement (the “Offering”), with Canaccord Genuity Corp., Eventus Capital Corp., Echelon Wealth Partners Inc., GMP Securities L.P. and PI Financial Corp. On May 24, 2017 the Company announced the closing of the private placement for aggregate gross proceeds of $25,008,750. Net proceeds from the Offering will be used for expansion plans for the Company’s assets and for general working capital purposes. As compensation, the Underwriters received a commission of 5% of the gross proceeds and a corporate finance fee of 5% of the gross proceeds.

On May 29, 2017, Invictus MD today unveiled their new responsive website, invictus-md.com. The new site features a more vibrant, attractive and compelling design that showcases Invictus MD’s unique personality. Larry Heinzlmeir, Vice President of Marketing and Communication commented:

“We also wanted to amplify the value that we deliver to our investors at large, both verbally and visually–to better communicate to all of our audiences. Today’s launch marks the beginning of a new era. It’s fresher, stronger, and more modern. It represents the optimism we all feel about how the future of the cannabis sector can contribute to society. Our new verbal and visual identity signifies that we’re transforming as an organization.”

Invictus MD Strategies Corp announced on June 23, 2017 its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”). HMMJ ETF is the first ETF to offer direct exposure to North American-listed stocks that operate in the legal medical cannabis industry. Horizon Medical Marijuana Life Sciences offers investors direct exposure to North American-listed stocks that are involved with biopharmaceuticals, medical manufacturing, distribution, bio-products, and other businesses ancillary to the marijuana industry. Invictus MD joins the 19 other constituents. Only stocks that meet minimum asset and liquidity thresholds are qualified for inclusion in the index, and no single stock may exceed 10% of the weight of the Index when rebalanced.

Invictus MD Strategies Corp’s 33% owned AB Labs announced on July 13, 2017 that has completed its first harvest, and anticipates a monthly harvest moving forward. These activities should begin generating significant revenue for the company moving into the second half of the year, which will scale up as the company increases production capacity over time. Management anticipates about 250 kilograms of production in 2017 before scaling up to 1,000 kilograms in future years.

AB Ventures — a subsidiary formed to develop a second licensed expansion facility in Hamilton, Ontario — is forging ahead with planning its Phase I expansion. The initial fully-funded $5.5 million expansion will be a 21,000-square foot purpose built facility capable of producing 3,000 kilograms per year. Management plans on completing this initial phase by the end of the year with plans to build an additional 21,000 square foot building envelope.

Acreage Pharms received a development permit for Phase II and has broken ground for the 27,800-square foot purpose built, multiple room production facility. The contracts and supplies necessary to complete the project have been scheduled and the company is prepared to invest $6 million toward the cost of constructing the production facility. The Phase III expansion will be a 76,750-square foot facility capable of producing 9,210 kilograms per year.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist